Status:
UNKNOWN
Evaluation of Advanced PRF Combined With Nano-crystalline Hydroxyapatite for Management of Grade II Furcation Defects
Lead Sponsor:
Hadeer Ashraf Hassan Roushdy
Conditions:
Periodontitis
Eligibility:
All Genders
Phase:
NA
Brief Summary
this study is to evaluate the use of advanced platelet rich fibrin (A-PRF) + nano-crystalline hydroxyapatite bone substitute combined with open flap debridement (OPD) versus open flap debridement alon...
Eligibility Criteria
Inclusion
- Patient-related criteria:
- Systemically healthy patients.
- Compliance with oral hygiene instructions and the maintenance program provided.
- Accepts the 6 months follow-up period.
- Provide informed consent.
- Teeth related criteria:
- Mature permanent tooth.
- Asymptomatic mandibular molar with buccal Glickman class II furcation involvement.
- Probing depth (PD) ≥ 5 mm and vertical PD ≥ 3 mm after Phase I therapy (scaling and root planing).
- Presence of radiolucency in the furcation area on an intra-oral periapical radiograph
Exclusion
- Patient-related criteria:
- Patients taking drugs known to interfere with periodontal wound healing in the last six months.
- Pregnant or nursing women.
- Smokers.
- Uncooperative patients.
- Teeth related criteria:
- Teeth with interproximal supra-bony or intrabony defects.
- Teeth with gingival recession.
- Teeth with grade II or III mobility.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03804086
Start Date
February 1 2019
End Date
February 1 2020
Last Update
January 17 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.